SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: margie who wrote (1894)9/29/1997 4:20:00 PM
From: JOHN W.   of 6136
 
Anyone that thought that the Barron's article was suspicious, look at today's the street.com. Could the shorts ask for anything more?-Not only the same negative article about AGPH posted multiple times throughout the day, but the hype of the other ICAAC news. Look at "late breaker" study. Look at the viral load at which the patients were at when they started the new PI. Crossen's downgrade based on a study never done by Agouron?

How many people think this is all just a coincidence and how many think that this merits an investigation?

If there was anything illegal done, they are taking a big risk for a lousy 4 points. Of course there is the possibility that I am just being paranoid and there was no hidden influence .
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext